Pulmonary haemorrhage and haemoptysis associated with bevacizumab-related treatment regimens: a retrospective, pharmacovigilance study using the FAERS database

• Egile Nagusiak: Huiping Hu (Egilea), Zhiwen Fu (Egilea), Jinmei Liu (Egilea), Cong Zhang (Egilea), Shijun Li (Egilea), Yu Zhang (Egilea), Ruxu You (Egilea)
• Formatua: Liburua
• Argitaratua: Frontiers Media S.A., 2024-06-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Background: Bevacizumab (BV) is widely used in routine cancer treatment and clinical therapy in combination with many other agents. This study aims to describe and analyse post-market cases of pulmonary haemorrhage and haemoptysis reported with different BV treatment regimens by mining data from the...